LINCOCIN Sterile Solution contains lincomycin hydrochloride which is the monohydrated salt of lincomycin, a substance produced by the growth of a member of the lincolnensis group of Streptomyces ...
Intramuscular administration of a single dose of 600 mg of lincomycin produces average peak serum concentrations of 11.6 mcg/mL at 60 minutes and maintains therapeutic concentrations for 17 to 20 ...
LINCOCIN Sterile Solution is indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for ...
This drug is contraindicated in patients previously found to be hypersensitive to lincomycin or clindamycin.
See BOXED WARNING. Clostridium difficile associated diarrhea - Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including ...
General - Review of experience to date suggests that a subgroup of older patients with associated severe illness may tolerate diarrhea less well. When LINCOCIN is indicated in these patients ...
The following adverse reactions have been reported with the use of lincomycin. Gastrointestinal disorders - Diarrhea, nausea, vomiting, glossitis, stomatitis, abdominal pain, abdominal ...
Serum concentrations of lincomycin are not appreciably affected by hemodialysis and peritoneal dialysis.
If significant diarrhea occurs during therapy, this antibacterial should be discontinued. (see BOXED WARNING) INTRAMUSCULAR - Adults - Serious infections—600 mg (2 mL) intramuscularly every 24 ...
LINCOCIN Sterile Solution is available in the following strength and package sizes: 300 mg - 2 mL Vials — NDC 0009-0555-01 - 10 mL Vials — NDC 0009-0555-02 - Each mL of LINCOCIN Sterile Solution ...
In vivo experimental animal studies demonstrated the effectiveness of LINCOCIN preparations (lincomycin) in protecting animals infected with Streptococcus viridans,β-hemolytic Streptococcus ...
Physically compatible for 24 hours at room temperature unless otherwise indicated. Infusion Solutions - 5% Dextrose Injection - 10% Dextrose Injection - 5% Dextrose and 0.9% Sodium Chloride ...
Rx only - This product's label may have been updated. For current full prescribing information, please visit www.pfizer.com - LAB-0138-11.0 - Revised November 2018
Pfizer - NDC 0009-0555-01 - Lincocin® lincomycin - injection, USP - 300 mg/mL - 1-2 mL
Pfizer - NDC 0009-0555-01 - Lincocin® lincomycin - injection, USP - 300 mg/mL* For intramuscular - or intravenous use - 1-2 mL Vial - Rx only
Quality First, Safety Guaranteed